The researchers found that, compared to the AGHE, the Mediterranean diet resulted in a significant decrease in waist ...

Lilly’s decision comes as the FDA has indicated potentially higher approval standards for drugs meant to preserve muscle in ...

Like many GLP-1 medications approved for diabetes, however, weight loss is a side effect of Rybelsus. “Data has shown modest ...

The 43-year-old retired tennis champ showcased her substantial weight loss in a animal-print teddy over black leggings, ...

Pharmacy benefit managers are working on a proposal to voluntarily change some business practices in an effort to avoid new ...

But -- finally -- Pfizer is getting into the obesity drug game. This past week, the company announced it will acquire Metsera ...

The decision to stop the Phase IIb study was driven by “strategic business reasons,” according to a federal clinical trials ...

Eli Lilly plans to launch its experimental oral weight-loss drug orforglipron in India, a senior executive said on Thursday, ...

“Semaglutide hits one receptor. It was the first one that came out,” Dr. Howe said. “Tirzepatide hits two receptors, and studies show that with tirzepatide, you get about a 32% weight loss compared to ...

Oral Ozempic alternative Orforglipron inspired the biggest biotech investment in Texas history, in Generation Park.

Pfizer is expediting its efforts to delve into the growing obesity treatment field with a nearly $5 billion acquisition. The ...

Delve into Eli Lilly’s biopharma strategy as it advances its pipeline, wins regulatory milestones, and forges strategic deals ...